MedTrace Logo

GDF-15 and Early Outcomes After LVAD Implantation

NCT07497308 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2026-03-27

No results posted yet for this study

Summary

This observational study aims to investigate the association between preoperative GDF-15 levels and early postoperative outcomes in patients undergoing left ventricular assist device (LVAD) implantation. The study will evaluate whether elevated preoperative GDF-15 levels are associated with adverse early outcomes, including postoperative complications and mortality. The findings may help improve preoperative risk assessment and identify high-risk patients before LVAD implantation.

Conditions

  • Advanced Heart Failure
  • Left Ventricular Assist Device Implantation

Sponsors & Collaborators

  • Akdeniz University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-04
Primary Completion
2026-08-10
Completion
2026-12-23

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07497308 on ClinicalTrials.gov